coronary artery occlusive disease
Showing 1 - 10 of 10
Sarcopenia Index on Postoperative Pulmonary Complication in
Completed
- Coronary Artery Occlusive Disease
-
Seoul, Korea, Republic ofDepartment of Anesthesiology and Pain Medicine, Yonsei Universit
Jul 27, 2021
Coronary Artery Occlusive Disease Trial in Seoul (Iloprost, Control (Normal saline))
Unknown status
- Coronary Artery Occlusive Disease
- Iloprost
- Control (Normal saline)
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Nov 4, 2020
Carotid IMT on Postoperative Cognitive Dysfunction in Patients
Completed
- Coronary Artery Occlusive Disease
-
Seoul, Korea, Republic ofDepartment of Anesthesiology and Pain Medicine, Anesthesia and P
May 9, 2019
Coronary Artery Occlusive Disease Trial in Seoul (Pravastatin 40mg, Rosuvastatin)
Completed
- Coronary Artery Occlusive Disease
- Pravastatin 40mg
- Rosuvastatin
-
Seoul, Korea, Republic ofSeverance Hospital
Jan 17, 2019
High Mobility Group Box 1 asPrognostic Biomarker in Patients
Completed
- Coronary Artery Occlusive Disease
-
Seoul, Korea, Republic ofDepartment of Anesthesiology & Pain Medicine, Yonsei university
Jun 20, 2018
Coronary Artery Occlusive Disease Trial in Seoul (Volume expansion)
Completed
- Coronary Artery Occlusive Disease
- Volume expansion
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Apr 18, 2013
Intraoperative Epiaortic Scanning for Preventing Early Stroke
Completed
- Coronary Artery Occlusive Disease
- (no location specified)
Jan 7, 2013
Coronary Artery Occlusive Disease Trial in Seoul (ulinastatin, saline solution)
Completed
- Coronary Artery Occlusive Disease
- ulinastatin, saline solution
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University College of Medicine
Jan 31, 2012
Coronary Artery Occlusive Disease Trial in Seoul (Tranexamic Acid)
Completed
- Coronary Artery Occlusive Disease
- Tranexamic Acid
-
Seoul, Korea, Republic ofYonsei Univ.
Dec 3, 2010
Coronary Artery Occlusive Disease Trial in Seoul (6% hydroxyethyl Stach 130/0.4)
Completed
- Coronary Artery Occlusive Disease
- 6% hydroxyethyl Stach 130/0.4
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 9, 2010